These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10896101)

  • 1. The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia.
    Hu LY; Ryder TR; Rafferty MF; Taylor CP; Feng MR; Kuo BS; Lotarski SM; Miljanich GP; Millerman E; Siebers KM; Szoke BG
    Bioorg Med Chem; 2000 Jun; 8(6):1203-12. PubMed ID: 10896101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
    Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties.
    Hu LY; Ryder TR; Rafferty MF; Feng MR; Lotarski SM; Rock DM; Sinz M; Stoehr SJ; Taylor CP; Weber ML; Bowersox SS; Miljanich GP; Millerman E; Wang YX; Szoke BG
    J Med Chem; 1999 Oct; 42(20):4239-49. PubMed ID: 10514294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.
    Knutsen LJ; Hobbs CJ; Earnshaw CG; Fiumana A; Gilbert J; Mellor SL; Radford F; Smith NJ; Birch PJ; Russell Burley J; Ward SD; James IF
    Bioorg Med Chem Lett; 2007 Feb; 17(3):662-7. PubMed ID: 17134896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.
    Yamamoto T; Niwa S; Tokumasu M; Onishi T; Ohno S; Hagihara M; Koganei H; Fujita S; Takeda T; Saitou Y; Iwayama S; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3639-42. PubMed ID: 22560585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
    Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
    Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
    Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Cysteine based N-type calcium channel blockers: structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takenobu Y; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2267-9. PubMed ID: 12161113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of 2-(1-alkylpiperidin-4-yl)-n-[(1r)-1-(4-fluorophenyl)-2-methylpropyl]acetamide Derivatives as Novel Antihypertensive Agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2012; 60(2):223-34. PubMed ID: 22293482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.
    Annoura H; Nakanishi K; Toba T; Takemoto N; Imajo S; Miyajima A; Tamura-Horikawa Y; Tamura S
    J Med Chem; 2000 Sep; 43(18):3372-6. PubMed ID: 10978184
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery, structure-activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity.
    Yamamoto T; Niwa S; Iwayama S; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Yamamoto H; Shoji M
    Bioorg Med Chem; 2006 Aug; 14(15):5333-9. PubMed ID: 16616501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2057-61. PubMed ID: 24726803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity.
    Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE
    Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.